Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

530
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
530
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

632
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
632
Glaucoma: Overview01:25

Glaucoma: Overview

704
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
704

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Five-Year Outcomes of Deep Sclerectomy in Pseudoexfoliation Glaucoma Compared to Primary Open-Angle Glaucoma.

Journal of clinical medicine·2024
Same author

[Virtual reality perimetry and home perimetry].

Die Ophthalmologie·2024
Same author

PRESERFLO MicroShunt implantation versus trabeculectomy for primary open-angle glaucoma: a two-year follow-up study.

Eye and vision (London, England)·2023
Same author

Implantation of XEN After Failed Trabeculectomy: an Efficient Therapy?

Klinische Monatsblatter fur Augenheilkunde·2021
Same author

Individualized Significance of 24-Hour Intraocular Pressure Curves for Therapeutic Decisions in Primary Chronic Open-Angle Glaucoma Patients.

Clinical ophthalmology (Auckland, N.Z.)·2020
Same author

Comparing the efficacy of trabeculectomy and diode laser cyclophotocoagulation in primary open-angle glaucoma.

International ophthalmology·2019
Same journal

[Real-world experience with aflibercept 8 mg for treatment of neovascular age-related macular degeneration after 12 months].

Die Ophthalmologie·2026
Same journal

[Vertigo and oculomotor disorders: diagnosis, anatomical classification and etiology].

Die Ophthalmologie·2026
Same journal

Die Ophthalmologie·2026
Same journal

[Calculating IOL power - principles, development and current challenges].

Die Ophthalmologie·2026
Same journal

[More than just technology: autonomous AI in ophthalmological care].

Die Ophthalmologie·2026
Same journal

[Is less more in individual cases? Minimal treatment for squamous cell carcinoma of the conjunctiva with orbital invasion].

Die Ophthalmologie·2026
See all related articles

Related Experiment Video

Updated: Aug 30, 2025

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.2K

[Therapy of malignant glaucoma].

J D Unterlauft1, M Schawkat2, N Häner2

  • 1Universitäts-Augenklinik Bern, Inselspital, Freiburgstr., 3010, Bern, Schweiz. jandarius.unterlauft@insel.ch.

Die Ophthalmologie
|August 29, 2022
PubMed
Summary
This summary is machine-generated.

Malignant glaucoma, a rare eye condition, has unclear causes but can be treated with medications or surgical interventions. This article details medicinal and surgical treatment options for malignant glaucoma.

Keywords:
Acute angle closureGlaucomaGlaucoma surgeryMalignant glaucomaVitrectomy

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.5K
Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

17.3K

Related Experiment Videos

Last Updated: Aug 30, 2025

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation
08:30

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

13.2K
Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

1.5K
Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres
06:35

Experimental Glaucoma Induced by Ocular Injection of Magnetic Microspheres

Published on: February 2, 2015

17.3K

Area of Science:

  • Ophthalmology
  • Medical Science

Context:

  • Malignant glaucoma is a rare and complex ocular disease.
  • The precise etiology of malignant glaucoma remains uncertain.

Purpose:

  • To present and justify medicinal and surgical treatment procedures for malignant glaucoma.
  • To provide a comprehensive overview of current therapeutic strategies.

Summary:

  • Treatment options for malignant glaucoma include pharmacological interventions.
  • Surgical approaches such as laser or open incisional surgery are also viable.
  • This review consolidates and explains the rationale behind these diverse treatment modalities.

Impact:

  • Aids clinicians in selecting appropriate treatments for malignant glaucoma.
  • Enhances understanding of management strategies for this rare condition.
  • Contributes to the body of knowledge on ocular disease treatment.